The FDA accepted a Priority Review BLA for RP1 and Opdivo in advanced melanoma ... A confirmatory, phase 3 IGNYTEE-3 trial is underway with over 100 sites planned globally. This trial will assess the ...

evaluating RP1 combined with nivolumab in patients with anti-PD-1 failed melanoma. A confirmatory Phase 3 trial, IGNYTE-3, is currently underway with over 100 sites planned globally.

Onchain data reveals that the number of Bitcoin wallets holding at least $100 is nearing all-time highs. According to Binance, the number of wallet addresses holding $100 or more surged from 24 ...

The BLA is supported by the primary analysis data of the IGNYTE trial, evaluating RP1 combined with nivolumab in patients with anti-PD-1 failed melanoma. A confirmatory Phase 3 trial, IGNYTE-3, is ...

The Social Affairs Ministry’s budget was reduced by Rp1.3 trillion from its total allocation of Rp79.5 trillion. This adjustment aligns with Presidential Instruction No. 1 of 2025 on expenditure ...

billboard hot 100™ the week’s most popular current songs across all genres, ranked by streaming activity from digital music sources tracked by luminate, radio airplay audience impressions as ...

billboard hot 100™ the week’s most popular current songs across all genres, ranked by streaming activity data by online music sources tracked by luminate, radio airplay audience impressions as ...

Starting with a small trading account, like $100, is one of the most accessible ways to dip your toes into the world of forex trading. Despite the modest sum, it's entirely possible to turn a ...

The biologics license application for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma was accepted by the FDA with priority review. The FDA accepted the biologics license ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The Hot 100 is the United States’ main singles chart, compiled by Billboard magazine based on sales, airplay and streams in the US. View the full Hot 100 here.